nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A current review of COVID-19 for the cardiovascular specialist
|
Lang, Joshua P. |
|
|
226 |
C |
p. 29-44 |
artikel |
2 |
Acute myocardial infarction under-diagnosis and mortality in a Tanzanian emergency department: A prospective observational study
|
Hertz, Julian T. |
|
|
226 |
C |
p. 214-221 |
artikel |
3 |
A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data
|
Wallace, Bryan C. |
|
|
226 |
C |
p. 161-173 |
artikel |
4 |
Anticipating and curtailing the cardiometabolic toxicity of social isolation and emotional stress in the time of COVID-19
|
Oren, Ohad |
|
|
226 |
C |
p. 1-3 |
artikel |
5 |
Back to the future—Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock?
|
Katz, Jason N. |
|
|
226 |
C |
p. 264-266 |
artikel |
6 |
Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City
|
Kuno, Toshiki |
|
|
226 |
C |
p. 24-25 |
artikel |
7 |
Cardiovascular implications of idiopathic pulmonary fibrosis: A way forward together?
|
Mosher, Christopher L. |
|
|
226 |
C |
p. 69-74 |
artikel |
8 |
Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging
|
Bottinor, Wendy J |
|
|
226 |
C |
p. 127-139 |
artikel |
9 |
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
|
Lopes, Renato D. |
|
|
226 |
C |
p. 49-59 |
artikel |
10 |
Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock
|
Smilowitz, Nathaniel R. |
|
|
226 |
C |
p. 255-263 |
artikel |
11 |
Corrigendum to “Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis” Am Heart J (2020)
|
Akao, Masaharu |
|
|
226 |
C |
p. 270 |
artikel |
12 |
COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports
|
Prasad, Anand |
|
|
226 |
C |
p. 174-187 |
artikel |
13 |
Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York
|
Braiteh, Nabil |
|
|
226 |
C |
p. 147-151 |
artikel |
14 |
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
|
Jackson II, Larry R. |
|
|
226 |
C |
p. 85-93 |
artikel |
15 |
Discrepancy in recognition of symptom burden among patients with atrial fibrillation
|
Katsumata, Yoshinori |
|
|
226 |
C |
p. 240-249 |
artikel |
16 |
Does central venous pressure really affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
|
Cheng, Yi |
|
|
226 |
C |
p. 253-254 |
artikel |
17 |
Does really central venous pressure affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
|
McCoy, Ian |
|
|
226 |
C |
p. 252 |
artikel |
18 |
Editorial Board
|
|
|
|
226 |
C |
p. v |
artikel |
19 |
Extending physicians’ reach in grasping AF symptoms
|
Mirwais, Maiwand |
|
|
226 |
C |
p. 250-251 |
artikel |
20 |
High-intensity endurance training is associated with left atrial fibrosis
|
Peritz, David C. |
|
|
226 |
C |
p. 206-213 |
artikel |
21 |
Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy
|
Folino, Antonio Franco |
|
|
226 |
C |
p. 26-28 |
artikel |
22 |
Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center
|
Abdelaziz, Hesham K. |
|
|
226 |
C |
p. 45-48 |
artikel |
23 |
Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?
|
Ha, Andrew C.T. |
|
|
226 |
C |
p. 152-160 |
artikel |
24 |
Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial
|
Jin, Aoming |
|
|
226 |
C |
p. 198-205 |
artikel |
25 |
Information for Readers
|
|
|
|
226 |
C |
p. vi |
artikel |
26 |
Levels of evidence supporting drug, device, and other recommendations in the American Heart Association/American College of Cardiology guidelines
|
Fanaroff, Alexander C. |
|
|
226 |
C |
p. 4-12 |
artikel |
27 |
Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation – Data from RACE 3
|
Nguyen, Bao-Oanh |
|
|
226 |
C |
p. 235-239 |
artikel |
28 |
Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations
|
Luo, Nancy |
|
|
226 |
C |
p. 13-23 |
artikel |
29 |
Overcoming underpowering: Trial simulations and a global rank end point to optimize clinical trials in children with heart disease
|
Hill, Kevin D. |
|
|
226 |
C |
p. 188-197 |
artikel |
30 |
Population-level surveillance of congenital heart defects among adolescents and adults in Colorado: Implications of record linkage
|
Crume, Tessa L. |
|
|
226 |
C |
p. 75-84 |
artikel |
31 |
Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?
|
Azevedo, Olga |
|
|
226 |
C |
p. 114-126 |
artikel |
32 |
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
|
Gommans, D. H. Frank |
|
|
226 |
C |
p. 60-68 |
artikel |
33 |
Smartphone 12-lead ECG—Exciting but must be handled with care
|
Lindow, Thomas |
|
|
226 |
C |
p. 267-268 |
artikel |
34 |
Smartphone 12-lead ECG—Exciting but must be handled with care
|
Muhlestein, Joseph Brent |
|
|
226 |
C |
p. 269 |
artikel |
35 |
Table of Contents
|
|
|
|
226 |
C |
p. i-iv |
artikel |
36 |
The RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs. health system Plus a collaborative/stepped care intervention to reduce hypertension disparities
|
Cooper, Lisa A. |
|
|
226 |
C |
p. 94-113 |
artikel |
37 |
The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients
|
Armstrong, Paul W. |
|
|
226 |
C |
p. 140-146 |
artikel |
38 |
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)
|
Berry, Natalia |
|
|
226 |
C |
p. 222-231 |
artikel |
39 |
Use and outcomes of wearable cardioverter-defibrillators in a large integrated academic health system
|
Kahn, Peter A. |
|
|
226 |
C |
p. 232-234 |
artikel |